About Genomic Valley Biotech Limited
Data last updated: 10 February 2026
Genomic Valley Biotech Limited is a public limited company based in Jhajjar, Haryana, India. It specialises in biotechnology, a part of the broader life sciences sector. Incorporated on 16 May 1994, the company has been in operation for over 32 years.
Registered with ROC Delhi under CIN L01122HR1994PLC033029. Listed on BSE: 539206.
Capital: an authorised share capital of ₹9 Cr and a paid-up capital of ₹3.05 Cr. It is led by directors including Satendra Kumar Goyal and Parul Agrawal.
Last AGM: 31 December 2025. Financial statements filed for year ended 31 March 2025. Office: 4 K.M.Stone Berri Chharra Road Vill. Kherka Musalman P.O.Tandaheri Teh Bahadu, Jhajjar, Haryana, India – 124507.
As per the financials filed for FY 2025, the company reported a revenue of ₹84.84 Lakh, reflecting significant growth compared to the previous year.
The company is associated with 1 brand - Genomic Valley Biotech. As per MCA filings, the company has satisfied charges of ₹3.74 Cr on record.
The current compliance status is marked as compliant by the Registrar of Companies. For more details, the company can be reached via its website genomicvalley.com.
-
Email*****@*****.com
-
Telephone+91-****-******
-
Website
-
Social Media**************
-
Registered Address4 K.M.Stone Berri Chharra Road Vill. Kherka Musalman P.O.Tandaheri Teh Bahadu, Jhajjar, Haryana, India – 124507
-
IndustryLife Sciences, Biotechnology
- Historical Financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Litigation, compliance and MCA filings
- PDF report delivered after checkout
CIN History of Genomic Valley Biotech Limited
Genomic Valley Biotech Limited has one previous CIN (Corporate Identification Number): L01122HR1996PLC033029. The current CIN is L01122HR1994PLC033029, which is the unique identifier assigned by the Registrar of Companies.
| CIN | Status |
|---|---|
| L01122HR1994PLC033029 | Current |
| L01122HR1996PLC033029 | Previous |
Associated Brands with Genomic Valley Biotech Limited
Genomic Valley Biotech Limited operates one associated brand: Genomic Valley Biotech. These brands represent Genomic Valley Biotech Limited's diversified market presence and brand portfolio.
| Brand | Description | Website |
|---|---|---|
| R&D company focused on plant tissue cultured plants | genomicvalley.com |
Business Activity of Genomic Valley Biotech Limited
Genomic Valley Biotech Limited is engaged in the principal business activity of agriculture, forestry, fishing, with detailed activities including support activities to agriculture and other activities including hunting.
| Main Activity Group Code | Description of Main Activity | Business Activity Code | Description of Business Activity | Turnover Percentage |
|---|---|---|---|---|
| A | Agriculture, forestry, fishing | A4 | Support activities to agriculture and Other Activities including hunting | ********* |
Auditor Details of Genomic Valley Biotech Limited
Genomic Valley Biotech Limited is audited by ANDROS & CO. (ICAI peer reviewed, certificate valid till 2027-12-31) for the financial year 2026, as reported in its BSE exchange filings. The statutory auditor is responsible for expressing an independent opinion on whether the financial statements present a true and fair view in accordance with applicable accounting standards.
| Name | Financial year | Audit opinion |
|---|---|---|
| ANDROS & CO. (ICAI peer reviewed, certificate valid till 2027-12-31) | FY 2026 | Declaration of unmodified opinion |
Board of Directors of Genomic Valley Biotech Limited
Genomic Valley Biotech Limited is currently managed by 6 directors, with 17 former directors having served the organization. The current Directors play a crucial role in shaping the company's strategic direction and governance.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
|
Satendra Kumar Goyal
Also directs:
Genomic Valley Biotech Limited, Purple Wave Infocom Limited
|
Director | 09 May 2024 | 2 Years 2 Months | Current |
|
Parul Agrawal
Also directs:
Genomic Valley Biotech Limited, Genomic Valley Bharat Private Limited, Eyoge Media Entertainment Private Limited and 1 more
|
Director | 14 Feb 2024 | 2 Years 4 Months | Current |
|
Ashok Kumar
Also directs:
Genomic Valley Biotech Limited
|
Additional Director | 14 Nov 2023 | 2 Years 7 Months | Current |
|
Yogainder Kumar Gupta
Also directs:
Genomic Valley Biotech Limited
|
Additional Director | 30 May 2025 | 1 Years 1 Months | Current |
|
Yogesh Agrawal
Also directs:
Genomic Valley Biotech Limited, Genomic Valley Bharat Private Limited, Eyoge Media Entertainment Private Limited and 3 more
|
Managing Director | 07 Sep 2015 | 10 Years 10 Months | Current |
Financials of Genomic Valley Biotech Limited FY 2026 filings available
Genomic Valley Biotech Limited reported revenue of ₹26.75 Lakh (down 68.3% YoY) for FY 2026. Profit growth despite declining revenue indicates effective cost management and margin discipline.
| Metrics | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
|---|---|---|---|---|---|---|---|---|
| Revenue from Operations | ₹26.75 Lakh | ₹84.39 Lakh | ₹16.51 Lakh | ₹2.72 Cr | ₹7.06 Lakh | ₹20.81 Lakh | ₹84.66 Lakh | ₹98.5 Lakh |
| Other Income | ₹0 | ₹45,000 | ₹15,000 | ₹4.26 Lakh | ₹8.4 Lakh | ₹29,000 | ₹1.41 Lakh | ₹1.48 Lakh |
| Total Income | ₹26.75 Lakh | ₹84.84 Lakh | ₹16.66 Lakh | ₹2.77 Cr | ₹15.46 Lakh | ₹21.1 Lakh | ₹86.07 Lakh | ₹99.98 Lakh |
| Cost of Materials Consumed | ₹0 | ₹0 | ₹0 | ₹0 | ₹19,400 | ₹50,000 | ₹88,300 | ₹4.72 Lakh |
| Purchases of Stock-in-Trade | ₹0 | ₹48.56 Lakh | ₹0 | ₹1.58 Cr | ₹0 | ₹0 | ₹0 | ₹0 |
| Changes in Inventories | ₹0 | -₹28.42 Lakh | ₹0 | ₹0 | ₹0 | ₹7.66 Lakh | -₹7.66 Lakh | ₹0 |
| Employee Benefit Expense | ₹10.59 Lakh | ₹12.09 Lakh | ₹3.75 Lakh | ₹14.96 Lakh | ₹13.99 Lakh | ₹8.58 Lakh | ₹17.65 Lakh | ₹26.69 Lakh |
| Finance Costs | ₹0 | ₹0 | ₹0 | ₹0 | ₹4.26 Lakh | ₹17.75 Lakh | ₹17.99 Lakh | ₹0 |
| Depreciation & Amortisation | ₹37,000 | ₹25,000 | ₹10,900 | ₹79,200 | ₹8.41 Lakh | ₹18.92 Lakh | ₹17.86 Lakh | ₹19.37 Lakh |
| Other Expenses | ₹11.79 Lakh | ₹8.22 Lakh | ₹11.28 Lakh | ₹11.07 Lakh | ₹30.69 Lakh | ₹17.88 Lakh | ₹18.77 Lakh | ₹25.73 Lakh |
| Total Expenses | ₹22.75 Lakh | ₹40.7 Lakh | ₹15.14 Lakh | ₹1.85 Cr | ₹57.54 Lakh | ₹71.29 Lakh | ₹65.49 Lakh | ₹76.51 Lakh |
| Profit Before Exceptional Items & Tax | ₹4 Lakh | ₹44.14 Lakh | ₹1.52 Lakh | ₹91.32 Lakh | -₹42.08 Lakh | -₹50.19 Lakh | ₹20.57 Lakh | ₹23.47 Lakh |
| Exceptional Items | ₹0 | ₹0 | ₹0 | -₹26.43 Lakh | ₹41.92 Lakh | ₹0 | ₹0 | ₹0 |
| Profit Before Tax | ₹4 Lakh | ₹44.14 Lakh | ₹1.52 Lakh | ₹64.89 Lakh | -₹16,500 | -₹50.19 Lakh | ₹20.57 Lakh | ₹23.47 Lakh |
| Total Tax Expense | ₹97,000 | ₹8.53 Lakh | -₹300 | ₹6,100 | ₹76,900 | ₹5.72 Lakh | -₹8.03 Lakh | ₹22,000 |
| Net Profit | ₹3.03 Lakh | ₹35.61 Lakh | ₹1.52 Lakh | ₹64.83 Lakh | -₹93,400 | -₹55.91 Lakh | ₹28.6 Lakh | ₹23.25 Lakh |
| Other Comprehensive Income | ₹0 | ₹0 | ₹0 | ₹0 | ₹0 | ₹0 | ₹0 | ₹0 |
| Total Comprehensive Income | ₹3.03 Lakh | ₹35.61 Lakh | ₹1.52 Lakh | ₹64.83 Lakh | -₹93,400 | -₹55.91 Lakh | ₹28.6 Lakh | ₹23.25 Lakh |
| EBITDA (computed) | ₹4.37 Lakh | ₹44.39 Lakh | ₹1.62 Lakh | ₹92.11 Lakh | -₹29.41 Lakh | -₹13.52 Lakh | ₹56.42 Lakh | ₹42.84 Lakh |
| Basic EPS | ₹0.10 | ₹1.17 | ₹0.05 | ₹2.12 | ₹-0.03 | ₹-1.83 | ₹0.94 | ₹0.76 |
| Diluted EPS | ₹0.10 | ₹1.17 | ₹0.05 | ₹2.12 | ₹-0.03 | ₹-1.83 | ₹0.94 | ₹0.76 |
| Metrics | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
|---|---|---|---|---|---|---|---|---|
| Total Assets | ₹4.25 Cr | ₹4.36 Cr | ₹4.33 Cr | ₹4.42 Cr | ₹3.8 Cr | ₹7.62 Cr | ₹8.01 Cr | ₹7.18 Cr |
| Non-current Assets | ₹1.55 Cr | ₹1.73 Cr | ₹1.42 Cr | ₹1.84 Cr | ₹2.66 Cr | ₹7.45 Cr | ₹7.6 Cr | ₹6.88 Cr |
| Current Assets | ₹2.7 Cr | ₹2.62 Cr | ₹2.91 Cr | ₹2.58 Cr | ₹1.14 Cr | ₹16.37 Lakh | ₹40.44 Lakh | ₹30.13 Lakh |
| Property, Plant & Equipment | ₹50,000 | ₹87,000 | ₹20,600 | ₹31,600 | ₹1.75 Cr | ₹5.86 Cr | ₹4.47 Cr | ₹4.31 Cr |
| Inventories | ₹28.42 Lakh | ₹28.42 Lakh | ₹0 | ₹0 | ₹0 | ₹0 | ₹12.4 Lakh | ₹11.87 Lakh |
| Trade Receivables | ₹2.32 Cr | ₹2.21 Cr | ₹2.53 Cr | ₹2.22 Cr | ₹0 | ₹6.49 Lakh | ₹10.27 Lakh | ₹5.83 Lakh |
| Cash & Equivalents | ₹44,000 | ₹2.29 Lakh | ₹22,900 | ₹0 | ₹0 | ₹0 | ₹3.19 Lakh | ₹31,000 |
| Equity (Net Worth) | ₹3.93 Cr | ₹3.9 Cr | ₹3.54 Cr | ₹3.53 Cr | ₹2.88 Cr | ₹4.49 Cr | ₹5.05 Cr | ₹4.76 Cr |
| Equity Share Capital | ₹3.05 Cr | ₹3.05 Cr | ₹3.05 Cr | ₹3.05 Cr | ₹3.05 Cr | ₹3.05 Cr | ₹3.05 Cr | ₹3.05 Cr |
| Borrowings (Non-current) | ₹0 | ₹0 | ₹0 | ₹0 | ₹0 | ₹1.55 Cr | ₹1.48 Cr | ₹1.48 Cr |
| Borrowings (Current) | ₹0 | ₹0 | ₹0 | ₹0 | ₹0 | ₹0 | ₹0 | ₹0 |
| Total Debt (computed) | ₹0 | ₹0 | ₹0 | ₹0 | ₹0 | ₹1.55 Cr | ₹1.48 Cr | ₹1.48 Cr |
| Current Liabilities | ₹32.08 Lakh | ₹45.79 Lakh | ₹79.14 Lakh | ₹89.33 Lakh | ₹21.43 Lakh | ₹87.13 Lakh | ₹76.85 Lakh | ₹7.28 Lakh |
| Total Liabilities | ₹32.11 Lakh | ₹45.84 Lakh | ₹79.16 Lakh | ₹89.35 Lakh | ₹91.88 Lakh | ₹3.13 Cr | ₹2.96 Cr | ₹2.42 Cr |
| Metrics | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|
| Operating Cash Flow | -₹1.9 Lakh | ₹2.72 Lakh | -₹2.01 Lakh | -₹1.04 Cr | -₹2.13 Cr |
| Investing Cash Flow | ₹0 | ₹1.19 Lakh | -₹1.52 Lakh | ₹1.79 Cr | ₹3.67 Cr |
| Financing Cash Flow | ₹0 | ₹0 | ₹0 | -₹70.45 Lakh | -₹1.55 Cr |
| Capital Expenditure | ₹0 | ₹91,000 | ₹0 | ₹0 | ₹0 |
| Free Cash Flow (computed) | -₹1.9 Lakh | ₹1.81 Lakh | -₹2.01 Lakh | -₹1.04 Cr | -₹2.13 Cr |
| Dividends Paid | ₹0 | ₹0 | ₹0 | ₹0 | ₹0 |
| Net Change in Cash | -₹1.9 Lakh | ₹4.52 Lakh | -₹3.52 Lakh | ₹3.86 Lakh | -₹87,700 |
| Metrics | Q4 FY26 | Q3 FY26 | Q2 FY26 | Q1 FY26 | Q4 FY25 | Q3 FY25 | Q2 FY25 | Q1 FY25 |
|---|---|---|---|---|---|---|---|---|
| Revenue from Operations | ₹3.75 Lakh | ₹5 Lakh | ₹9 Lakh | ₹9 Lakh | ₹26.35 Lakh | ₹22.01 Lakh | ₹20.5 Lakh | ₹15.53 Lakh |
| Other Income | ₹0 | ₹0 | ₹0 | ₹0 | ₹1,000 | ₹4,300 | ₹72,000 | ₹0 |
| Total Income | ₹3.75 Lakh | ₹5 Lakh | ₹9 Lakh | ₹9 Lakh | ₹26.36 Lakh | ₹22.05 Lakh | ₹21.22 Lakh | ₹15.53 Lakh |
| Cost of Materials Consumed | ₹0 | ₹0 | ₹0 | ₹0 | ₹0 | ₹0 | ₹0 | ₹0 |
| Purchases of Stock-in-Trade | ₹0 | ₹0 | ₹0 | ₹0 | ₹48.56 Lakh | ₹0 | ₹0 | ₹0 |
| Changes in Inventories | ₹0 | ₹0 | ₹0 | ₹0 | -₹28.42 Lakh | ₹0 | ₹0 | ₹0 |
| Employee Benefit Expense | ₹45,000 | ₹2.25 Lakh | ₹3.75 Lakh | ₹4.14 Lakh | ₹4.14 Lakh | ₹3.21 Lakh | ₹3.54 Lakh | ₹1.2 Lakh |
| Finance Costs | ₹0 | ₹0 | ₹0 | ₹0 | ₹0 | ₹0 | ₹0 | ₹0 |
| Depreciation & Amortisation | ₹13,000 | ₹8,000 | ₹8,000 | ₹8,000 | ₹10,000 | ₹5,000 | ₹10,000 | ₹0 |
| Other Expenses | ₹3.01 Lakh | ₹1.62 Lakh | ₹4.84 Lakh | ₹2.31 Lakh | ₹1.79 Lakh | ₹3.26 Lakh | ₹2.83 Lakh | ₹1.57 Lakh |
| Total Expenses | ₹3.59 Lakh | ₹3.95 Lakh | ₹8.67 Lakh | ₹6.53 Lakh | ₹26.17 Lakh | ₹6.52 Lakh | ₹6.47 Lakh | ₹2.77 Lakh |
| Profit Before Exceptional Items & Tax | ₹16,000 | ₹1.05 Lakh | ₹33,000 | ₹2.47 Lakh | ₹19,000 | ₹15.54 Lakh | ₹14.76 Lakh | ₹12.76 Lakh |
| Exceptional Items | ₹0 | ₹0 | ₹0 | ₹0 | ₹0 | ₹0 | ₹0 | ₹0 |
| Profit Before Tax | ₹16,000 | ₹1.05 Lakh | ₹33,000 | ₹2.47 Lakh | ₹19,000 | ₹15.54 Lakh | ₹14.76 Lakh | ₹12.76 Lakh |
| Total Tax Expense | ₹97,000 | ₹0 | ₹0 | ₹0 | ₹8.53 Lakh | ₹0 | ₹0 | ₹0 |
| Net Profit | -₹81,000 | ₹1.05 Lakh | ₹33,000 | ₹2.47 Lakh | -₹8.34 Lakh | ₹15.54 Lakh | ₹14.76 Lakh | ₹12.76 Lakh |
| Other Comprehensive Income | ₹0 | ₹0 | ₹0 | ₹0 | ₹0 | ₹0 | ₹0 | ₹0 |
| Total Comprehensive Income | -₹81,000 | ₹1.05 Lakh | ₹33,000 | ₹2.47 Lakh | -₹8.34 Lakh | ₹15.54 Lakh | ₹14.76 Lakh | ₹12.76 Lakh |
| EBITDA (computed) | ₹29,000 | ₹1.13 Lakh | ₹41,000 | ₹2.55 Lakh | ₹29,000 | ₹15.59 Lakh | ₹14.86 Lakh | ₹12.76 Lakh |
| Basic EPS | ₹-0.03 | ₹0.03 | ₹0.01 | ₹0.08 | ₹-0.27 | ₹0.51 | ₹0.48 | ₹0.42 |
| Diluted EPS | ₹-0.03 | ₹0.03 | ₹0.01 | ₹0.08 | ₹-0.27 | ₹0.51 | ₹0.48 | ₹0.42 |
Shareholding Pattern of Genomic Valley Biotech Limited
As per the shareholding pattern filed with BSE for the quarter ended Mar 2026, promoters hold 46.06%, retail and other public shareholders hold 53.94% of Genomic Valley Biotech Limited. The company had 2,481 shareholders on record.
| Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 | |
|---|---|---|---|---|---|---|
| Promoters | 46.06% | 46.06% | 46.72% | 46.72% | 46.78% | 46.83% |
| Public | 53.94% | 53.94% | 53.28% | 53.28% | 53.22% | 53.17% |
| Mar 2026 | Mar 2025 | Mar 2024 | |
|---|---|---|---|
| Promoters | 46.06% | 46.78% | 64.20% |
| Public | 53.94% | 53.22% | 35.80% |
| Promoter change (YoY, %pts) | -0.72 | -17.42 | - |
Charges & Borrowings of Genomic Valley Biotech Limited
| Date | Lender | Amount | Status |
|---|---|---|---|
| 27 Apr 2021 | Others | ₹2.26 Cr | Satisfied |
| 30 Apr 2019 | Others | ₹1.48 Cr | Satisfied |
Total charge records: 2 View all charges
Employees and EPFO Compliance at Genomic Valley Biotech Limited
View historical data on people associated with Genomic Valley Biotech Limited, including employment history and EPFO contributions.
Employee Count & EPFO Data of Genomic Valley Biotech Limited
Access employee headcount trends, monthly PF payment records, EPFO establishment details, and compliance data.
GST Compliance of Genomic Valley Biotech Limited
GSTIN & GST Filing Data of Genomic Valley Biotech Limited
Access GSTIN registrations, state-wise filing compliance, HSN/SAC codes, and detailed goods & services data.
Credit Ratings, Litigation & Regulatory Alerts for Genomic Valley Biotech Limited
Credit Ratings, Legal Cases & Regulatory Alerts of Genomic Valley Biotech Limited
Access complete credit rating history, litigation records, regulatory alerts, and compliance data.
MSME Payment Delays by Genomic Valley Biotech Limited
MSME Payment Delays by Genomic Valley Biotech Limited
Track payments outstanding to micro and small enterprise vendors, as disclosed in half-yearly MSME-1 returns filed with the MCA.
Subsidiaries & Group Companies of Genomic Valley Biotech Limited
Subsidiaries & Group Companies of Genomic Valley Biotech Limited
See the full corporate group - holding company, subsidiaries, associates and joint ventures of Genomic Valley Biotech Limited with ownership details.
MCA Filings & Documents of Genomic Valley Biotech Limited
MCA Filings & Documents of Genomic Valley Biotech Limited
Download official documents filed with the Ministry of Corporate Affairs - from incorporation papers to the latest annual filings.
Recent Activity on Genomic Valley Biotech Limited
Frequently Asked Questions about Genomic Valley Biotech Limited
Genomic Valley Biotech Limited is an active public limited company in the life sciences sector based in Jhajjar, Haryana, India. It was incorporated on 16 May 1994 (32+ years old) and is registered under CIN L01122HR1994PLC033029. Listed on BSE: 539206.
Genomic Valley Biotech Limited reported revenue of ₹84.84 Lakh for FY 2025 (up 409.00% YoY).
The current directors of Genomic Valley Biotech Limited are:
- Yogesh Agrawal
- Satendra Kumar Goyal
- Parul Agrawal
- Anupam Aditya
- Ashok Kumar
- Yogainder Kumar Gupta
The primary industry of Genomic Valley Biotech Limited is life sciences. The company specifically operates in biotechnology. The company is currently active in this sector.
Yes. Genomic Valley Biotech Limited is listed on BSE with code 539206.
Genomic Valley Biotech Limited can be reached at the registered office: 4 K.M.Stone Berri Chharra Road Vill. Kherka Musalman P.O.Tandaheri Teh Bahadu, Jhajjar, Haryana, India – 124507, or through the website genomicvalley.com.